VKTX fund manager activity
Viking Therapeutics, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q1 2023 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | Trimmed | 125,827 | $4,426,594 | 0.01% | Feb 17, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 239,229 | $8,416,076 | 0.03% | Feb 17, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | No change | 126,737 | $3,330,648 | 0.01% | Nov 14, 2025 |
| Stanley Druckenmiller - Duquesne Family Office | Sold out | — | — | 0.00% | Nov 14, 2025 |
| Joel Greenblatt - Gotham Asset Management | New | 169,683 | $4,459,269 | 0.02% | Nov 14, 2025 |